Literature DB >> 3767695

Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.

S Parthasarathy, D J Printz, D Boyd, L Joy, D Steinberg.   

Abstract

Incubation of low density lipoprotein (LDL) with endothelial cells or smooth muscle cells overnight has resulted in an oxidative modification of LDL that results in its recognition by macrophages by way of the acetyl LDL receptor. In the present study, we examined whether macrophages themselves can oxidize and modify LDL in a manner similar to that of endothelial cells. Incubation of 125I-labeled LDL with resident or thioglycollate-elicited macrophages for 24 hours in Ham's F-10 medium resulted in the appearance of thiobarbituric acid (TBA) reactive materials and trichloroacetic acid (TCA) soluble radioactivity in the medium. The LDL harvested from these incubations showed increased electrophoretic mobility and was degraded rapidly when added to fresh macrophages as compared to LDL previously incubated in the absence of cells. These macrophage-induced modifications could be prevented if the first incubation was carried out in the presence of the antioxidant butylated hydroxytoluene (BHT) or in Dulbecco's modified Eagle's medium (DMEM). The degradation of 125I-labeled macrophage-modified LDL by macrophages was competitively inhibited by unlabeled acetyl LDL or unlabeled endothelial cell-modified LDL but not by native LDL, indicating that the degradation was mediated by the acetyl LDL receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767695     DOI: 10.1161/01.atv.6.5.505

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  64 in total

1.  Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.

Authors:  O Jaakkola; T Nikkari
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 2.  Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.

Authors:  S Chatterjee
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

3.  Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; C K Glass; E Sigal; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  The action of defined oxygen-centred free radicals on human low-density lipoprotein.

Authors:  S Bedwell; R T Dean; W Jessup
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Interaction between sphingomyelin and oxysterols contributes to atherosclerosis and sudden death.

Authors:  Fred A Kummerow
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

7.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 8.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

9.  Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit.

Authors:  H C Huang; Y I Weng; C R Lee; T R Jan; Y L Chen; Y T Lee
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Smoking influences the atherogenic potential of low-density lipoprotein.

Authors:  E Scheffler; E Wiest; J Woehrle; I Otto; I Schulz; L Huber; R Ziegler; H A Dresel
Journal:  Clin Investig       Date:  1992 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.